Skip to content

Advertisement

  • Research article
  • Open Access
  • Open Peer Review

Is there association between Glutathione S Transferases polymorphisms and cataract risk: a meta-analysis?

†Contributed equally
BMC Ophthalmology201515:84

https://doi.org/10.1186/s12886-015-0065-4

©  Sun et al. 2015

  • Received: 15 March 2015
  • Accepted: 6 July 2015
  • Published:
Open Peer Review reports

Abstract

Background

Glutathione S transferase (GST) polymorphisms have been considered as risk factors for age-related cataracts, but the results remain controversial. In this study, we have performed a meta-analysis to evaluate the association between polymorphisms of GSTM1 and GSTT1 and cataract risk.

Methods

Published literature from PubMed and other databases were retrieved. The case–control studies regarding the association between GSTM1 or GSTT1 polymorphism and cataract risk were included. Pooled odds ratio (OR) and 95 % confidence interval (CI) were calculated using random- or fixed-effects model.

Results

Fifteen studies on GSTM1 (3,065 patients and 2,105 controls), and nine studies on GSTT1 (2,374 patients and 1,544 controls) were included. By pooling all the studies, GSTM1 null polymorphism was not associated with cataract risk, and this negative association maintained in subgroup analyses. However, GSTT1 null polymorphism was significantly associated with increased risk of posterior subcapsular (OR, 1.42; 95 % CI, 1.04–1.94) but not other subtypes of cataract. Stratified analyses demonstrated an association of GSTT1 null genotype with increased risk of cataract in Asian (OR, 1.44; 95 % CI, 1.14–1.83) but not Caucasian populations. In addition, seven pooled studies showed no association of cataract risk with the combined GSTM1 and GSTT1 null genotypes.

Conclusions

This meta-analysis suggests that GSTT1 null polymorphism is associated with increased risk of posterior subcapsular cataract. Given the limited sample size, the association between GSTT1 null polymorphism and cataract risk in Asian awaits further investigation.

Keywords

  • Glutathione S Transferases
  • Polymorphisms
  • Cataract
  • Meta-analysis

Background

Cataract is the opacification of eye lens with the breakdown of the lens protein microarchitecture, which adversely affects the transmission of light onto the retina [1]. Recent data suggest that cataract remains the leading cause of blindness worldwide, and the age-related cataract accounts for approximately 50 % of blindness cases [2]. Epidemiologic studies have revealed some environmental risk factors for age-related cataract, including ultraviolet B light exposure, ionizing radiation, smoking, and use of steroids [3]. Recently, genetic factors have been found to play important roles in the pathogenesis of age-related cataract [4]; furthermore, gene polymorphisms have been reported to be associated with age-related cataract risk [5, 6].

It has been reported that oxidative stress contributes to development of age-related cataract [7]. Biochemical evidence demonstrates that generation of excessive reactive oxygen species (ROS) results in abnormal degradation, cross linking, and aggregation of lens proteins, and is involved in cataractogenesis [8]. The oxidative damage during cataractogenesis can be alleviated by cellular defense mechanisms, including catalase, superoxide dismutase, glutathione peroxidase, and glutathione S transferases (GSTs) in the eye [9]. Among them, GSTs are a superfamily of enzymes that play important roles in the detoxification, elimination of xenobiotics and antioxidation, such as carcinogens, toxins, oxidants and drugs [10]. This enzymatic superfamily is composed of three different families: mitochondrial, microsomal and cytosolic. The cytosolic family of GSTs are classified in seven classes based on chromosomal location and on sequence similarity: alpha (GSTA), mu (GSTM), pi (GSTP), theta (GSTT), kappa (GSTK), zeta (GSTZ) and omega (GSTO) [11].

Previous studies have identified numerous variants in GST genes, and some of these polymorphisms are functional, e.g., GSTT1 and GSTM1 null polymorphisms [12]. In fact, the deletion of GSTT1 or GSTM1 results in dysfunction of their enzyme activity [12], and these polymorphisms of GST are associated with increased risks of various pathologies including cancers [13] and ophthalmologic problems such as glaucoma [14]. The relationships between GST polymorphisms and risks of age-related cataract have been studied for many years, and an early meta-analysis suggested that GSTM1 and GSTT1 null genotypes were associated with increased risk for senile cataract in Asians but not Caucasians [6]. However, recent studies showed that GSTM1 positive (GSTM1 +/+ ) genotype was associated with a susceptibility to age-related cortical cataract in Asians [15], while GSTM1 or GSTT1 null genotype was associated with age-related cataract risk in Caucasians [16, 17]. These inconsistent results may be due to the relatively small size of study populations from each individual study, or limited studies included by the previous meta-analysis; therefore, in this study we have conducted an update meta-analysis to reevaluate the associations between GSTM1 and GSTT1 polymorphisms and age-related cataract risk.

Methods

Identification of eligible studies

To identify all articles that evaluated the association of GST polymorphism with cataract, we carried out a literature search in the PubMed databases up to December 2014 with the following MeSH terms and keywords: “cataract”, “glutathione S transferase”, and “polymorphism”. The manual search was conducted to identify additional studies from other sources (e.g., Embase, Web of Knowledge, China National Knowledge Infrastructure), review articles on this topic or references to original studies. The inclusion criteria for eligible studies included in this meta-analysis as follows: (a) a study evaluating the association between GSTM1 or GSTT1 null polymorphism and cataract, (b) a case–control study, (c) an unrelated study, if studies had partly overlapped subjects, only the one with a larger sample size was selected, (d) a study with available genotype frequency, and (e) a study with sufficient data for estimating odds ratio (OR) and 95 % confidence interval (CI). Our meta-analysis was in accordance with PRISMA guidelines

Because the data included in this study were retrieved from the literatures, written informed consent for participation and ethical approval have been provided by original studies. Thus, all investigations analyzed in this meta-analysis have been carried out in compliance with the Helsinki Declaration.

Data extraction

Two investigators (W.S. and L.S) independently assessed the articles for inclusion, and reached a consensus on data extracted. For each study, the following information was extracted: the first author name and publication year of the article; ethnicity (country) of study subjects; gene polymorphisms and genotype frequencies; sample size (numbers of cases and controls); sources of controls; subtypes of cataract classified. The missing data and information of included studies were obtained by contacting the study authors through email.

Statistical analysis

The association between GSTM1, or GSTT1 polymorphism and cataract was estimated by calculating pooled OR and 95 % CI. The significance of the pooled OR was determined by Z test, in which the P < 0.05 was considered statistically significant. The risk of GSTM1 or GSTT1 null genotype on cataract was evaluated by comparing to wild type homozygote as their reference. Stratified analyses were also performed by ethnicity of study populations, the source of controls, gender of subjects, and cataract subtype. Considering the possible additive effect of different GST genotypes, we next evaluated the association between the genotype profile and cataract risk, in which the individuals with two putative low-risk genotypes, i.e.,, the presence of functional GSTM1 and GSTT1 alleles, were used as reference group [18]. For the quantitative synthesis analysis, the environmental effects were not adjusted due to the lack of information from the original study. The I2-based Q statistic test was applied to examine variations due to heterogeneity rather than chance. A random-effects (DerSimonian-Laird method) model or fixed-effects (Mantel-Haenszel method) model was applied to calculate pooled effect estimates in the presence (P ≤ 0.10) or absence (P > 0.10) of heterogeneity. The Egger’s test [19] and the Begg’s [20] test were applied to detect publication bias for the overall pooled analysis of GSTM1 or GSTT1 null genotypes. Additionally, the Begg’s funnel plot was obtained, in which an asymmetry of the funnel plot indicates a potential publication bias. The one-way sensitivity analysis was performed when one single study was excluded each time, and the new pooled results reflect the influence of the study deleted to the overall OR. All analyses were carried out with Stata software (version 11.0; Stata Corp LP, College Station, TX), and the two-sided P values were applied.

Results

Characteristics of studies

By searching PubMed, fifteen abstracts were retrieved through the search “cataract” “glutathione S transferase” and “polymorphism”, and nine studies meeting the inclusion criteria were identified as eligible [15–18, 21–25]. Out of the fifteen, one was meta-analysis [6] and one was laboratory study [26]. One article was excluded due to investigation on an association of presenile cataracts with heterozygosity for galactosaemic states and with riboflavin deficiency [27]. We excluded two articles on the relationship between GST polymorphisms and risk of age-related macular degeneration [28] or primary open-angle glaucoma [29]. We also excluded one article that examined the association of GSTO polymorphisms with cataract risk [30]. In addition, we included six eligible articles with manual searching [31–36]. As a result, a total of fifteen articles on GSTM1 or GSTT1 polymorphisms meeting the inclusion criteria were identified as eligible studies (Fig. 1).
Fig. 1
Fig. 1

Flow diagram of studies identification

Fifteen studies on GSTM1 (3,065 cases and 2,105 controls), and nine studies on GSTT1 (2,374 cases and 1,544 controls) were included in this meta-analysis. For the ethnicities, six studies of Asians and eight studies of Caucasians were included on the GSTM1 genotype. As to GSTT1, two studies of Asians and six studies of Caucasians were included. We also grouped studies with different sources of controls (i.e., population-based or hospital-based), gender (male or female) and subtypes of cataracts (e.g., cortical, nuclear, posterior sub-capsular or mixed cataract). In addition to the study by Juronen et al. [25] that determined the GSTM1 and GSTT1 phenotypes by enzyme-linked immunosorbent assay (ELISA), the genotyping for GSTM1, or GSTT1 was determined by polymerase chain reaction (PCR) assay in all other studies. The Table 1 presents the detailed characteristics of each study included in the meta-analysis.
Table 1

Characteristics of literatures included in the meta-analysis

Author/ Year

Country

Ethnicity

Sample size Cases/controlsa

Source of controls

Cataract subtype

GSTM1

     

Sekine 1995 [36]

Japan

Asian

138/62 (101/30)

PB

Not classified

Alberti 1996 [35]

United States

Caucasian

202/98 (99/49)

HB

NC/CC/M

Pi 1996 [34]

China

Asian

59/112 (41/57)

HB

Not classified

Hao 1999 [33]

China

Asian

77/76 (41/35)

HB

Not classified

Juronen 2000 [25]

Estonia

Caucasian

503/202 (240/111)

HB

CC/NC/ PSC/M

Saadat 2004 [24]

Iran

Caucasian

150/150 (90/58)

HB

Not classified

Saadat 2006 [23]

Iran

Caucasian

95/95 (56/36)

HB

Not classified

Guven 2007 [18]

Turkey

Caucasian

195/136 (105/58)

HB

CC/NC/ PSC/MC

Xu 2007 [32]

China

Asian

120/118 (81/60)

HB

Not classified

Azeem 2009 [22]

Egypt

Caucasian

53/73 (23/46)

HB

Not classified

Zhou 2010 [21]

China

Asian

279/145 (171/95)

PB

Not classified

Sireesha 2012 [16]

India

Caucasian

455/205 (177/94)

PB

CC/NC/ PSC/MC

Saadat 2012 [17]

Iran

Caucasian

186/195 (104/89)

HB

Not classified

Jiang 2012 [15]

China

Asian

422/312 (176/173)

HB

CC

Chandra 2014 [31]

India

Caucasian

124/126 (43/68)

HB

Not classified

GSTT1

     

Juronen 2000 [ 25]

Estonia

Caucasian

503/202 (73/36)

HB

CC/NC/PSC/MC

Saadat 2004 [24]

Iran

Caucasian

150/150 (49/46)

HB

Not classified

Guven 2007 [18]

Turkey

Caucasian

195/136 (29/22)

HB

CC/NC/PSC/MC

Azeem 2009 [22]

Egypt

Caucasian

53/73 (16/21)

HB

Not classified

Zhou 2010 [21]

China

Asian

279/145 (146/60)

PB

CC/NC/PSC

Sireesha 2012 [16]

India

Caucasian

455/205 (123/40)

PB

CC/NC/PSC/MC

Saadat 2012 [17]

Iran

Caucasian

186/195 (49/57)

HB

Not classified

Jiang 2012 [15]

China

Asian

422/312 (221/138)

HB

CC

Chandra 2014 [ 31]

India

Caucasian

131/126 (18/5)

HB

Not classified

Abbreviations: PB population-based, HB hospital-based, CC cortical cataract, NC nuclear cataract, PSC posterior sub-capsular cataract, MC mixed cataract

aThe number of null genotype cases or controls was presented in parenthesis

Quantitative synthesis

Table 2 shows the results of the meta-analysis on the association of GSTM1 or GSTT1 null polymorphism with cataract risk. When pooling all the studies, we found that GSTM1 null polymorphism was not associated with cataract risk (Fig. 2a), and this negative association maintained in either Caucasian or Asian populations (Table 2). When stratified by the source of controls, gender, or cataract subtype, no association was found between GSTM1 null polymorphism and cataract risk.
Table 2

Association between GSTM1 or GSTT1 polymorphism and cataract risk

Groups

Na

Statistical methodb

OR (95 % CI)

P

GSTM1

    

All

15

Random (P < 0.001)

1.17 (0.88–1.57)

0.288

 Ethnics

    

 Caucasian

9

Random (P < 0.001)

1.07 (0.753–1.53)

0.712

 Asian

6

Random (P < 0.001)

1.37 (0.79–2.40)

0.266

Study design

    

 Population-based

3

Random (P = 0.001)

1.17 (0.58–2.33)

0.666

 Hospital-based

12

Random (P < 0.001)

1.18 (0.84–1.65)

0.350

Gender

    

 Male

5

Random (P = 0.035)

0.89 (0.58–1.37)

0.598

 Female

5

Random (P < 0.001)

1.02 (0.44–2.32)

0.970

Subtype

    

 Cortical

4

Random (P = 0.086)

0.85 (0.59–1.23)

0.386

 Nuclear

4

Random (P = 0.084)

0.97 (0.62–1.52)

0.904

 Posterior subcapsular

3

Fixed (P = 0.242)

0.98 (0.72–1.32)

0.879

 Mixed

4

Random (P = 0.040)

0.94 (0.60–1.48)

0.792

GSTT1

    

All

9

Random (P = 0.049)

1.20 (0.96–1.51)

0.105

Ethnics

    

 Caucasian

7

Random (P = 0.058)

1.11 (0.83–1.49)

0.474

 Asian

2

Fixed (P = 0.653)

1.44 (1.14–1.83)

0.003

Study design

    

 Population-based

2

Fixed (P = 0.952)

1.54 (1.16–2.05)

0.003

 Hospital-based

7

Random (P = 0.063)

1.10 (0.84–1.45)

0.498

Gender

    

 Male

5

Fixed (P = 0.984)

1.29 (0.98–1.70)

0.073

 Female

5

Fixed (P = 0.359)

1.28 (0.97–1.69)

0.078

Subtype

    

 Cortical

4

Fixed (P = 0.186)

1.09 (0.82–1.45)

0.555

 Nuclear

4

Random (P = 0.062)

0.92 (0.52–1.62)

0.774

 Posterior subcapsular

4

Fixed (P = 0.219)

1.42 (1.04–1.94)

0.026

 Mixed

3

Random (P = 0.097)

1.21 (0.66–2.20)

0.535

aN: The number of included studies

bA random-effects or fixed-effects model was used in presence (P ≤ 0.10) or absence (P > 0.10) of heterogeneity of included studies and the P value was presented in parenthesis

Fig. 2
Fig. 2

Forest plots of the association between GSTM1 or GSTT1 null polymorphism and cataract risk. The random-effects or fixed model was used to calculate the pooled effect estimates of the effects of GSTM1 (a) or GSTT1 (b) null polymorphism on cataract risk respectively. The squares and horizontal lines correspond to OR and 95 % CI of specific study, and the area of squares reflects study weight (inverse of the variance). The diamond represents the pooled OR and its 95 % CI

For GSTT1, the overall result showed that GSTT1 null polymorphism was significantly associated with increased risk of cataract in Asian (OR, 1.44; 95 % CI, 1.14–1.83) but not Caucasian populations (Table 2). The positive association of GSTT1 null polymorphism with increased risk of cataract was found when pooling studies with population-based (OR, 1.54; 95 % CI, 1.16–2.05) but not hospital-based controls. However, there was no association between GSTT1 null polymorphism and cataract risk in male or female subjects. Interestingly, GSTT1 null polymorphism was associated with risk of posterior subcapsular (OR, 1.42; 95 % CI, 1.04–1.94) but not other subtypes of cataract.

We next investigated the effects of the profiles of GST genotypes on the risk of cataract, and examined the association between combinations of GSTM1 and GSTT1 null genotypes and cataract risk. Table 3 displays cataract risk associated with combinations of GST null genotypes, and the trend in risk associated with each putative high-risk null genotype. The results showed no association between the combined GSTM1 and GSTT1 null genotypes and cataract risk in all population, Caucasian or Asian population. When stratified by source of controls, pooled two studies with population-based controls showed that combination of GSTM1 null and GSTT1 positive (GSTT1 +/+ ) genotypes played a protective role in cataract risk (OR, 0.71; 95 % CI, 0.54–0.92), but combination of GSTM1 positive and GSTT1 null, or GSTM1 and GSTT1 null genotypes was not associated with cataract risk. The other sub-group analyses showed no association between combination of GSTM1 and GSTT1 polymorphisms and cataract risk.
Table 3

Association between GSTM1 and GSTT1 polymorphisms and cataract risk

Groups

Numbera

Statistical methodb

OR (95 % CI)

P

All

    

GSTM1 null + GSTT1 positive

7

Random (P < 0.001)

0.83 (0.56– 1.23)

0.356

GSTM1 positive + GSTT1 null

7

Fixed (P = 0.240)

1.20 (0.95– 1.53)

0.134

GSTM1 null + GSTT1 null

7

Random (P = 0.010)

1.16 (0.71– 1.89)

0.545

Ethnics

    

Caucasian

    

  GSTM1 null + GSTT1 positive

6

Random (P < 0.001)

0.85 (0.52– 1.37)

0.494

  GSTM1 positive + GSTT1 null

6

Fixed (P = 0.658)

1.00 (0.74– 1.34)

0.983

  GSTM1 null + GSTT1 null

6

Random (P = 0.008)

1.27 (0.67– 2.38)

0.466

Study design

    

PB

    

  GSTM1 null + GSTT1 positive

2

Fixed (P = 0.591)

0.71 (0.54– 0.92)

0.009

  GSTM1 positive + GSTT1 null

2

Fixed (P = 0.334)

1.03 (0.69– 1.53)

0.899

  GSTM1 null + GSTT1 null

2

Random (P = 0.036)

0.87 (0.34– 2.18)

0.760

HB

    

  GSTM1 null + GSTT1 positive

5

Random (P < 0.001)

0.88 (0.47– 1.65)

0.697

  GSTM1 positive + GSTT1 null

5

Fixed (P = 0.196)

1.32 (0.97– 1.79)

0.073

  GSTM1 null + GSTT1 null

5

Random (P = 0.024)

1.38 (0.71– 2.69)

0.336

Gender

    

Male

    

  GSTM1 null + GSTT1 positive

2

Fixed (P = 0.990)

0.88 (0.49– 1.59)

0.676

  GSTM1 positive + GSTT1 null

2

Fixed (P = 0.476)

0.84 (0.28– 2.50)

0.749

  GSTM1 null + GSTT1 null

2

Fixed (P = 0.672)

1.48 (0.52– 4.21)

0.463

Female

    

  GSTM1 null + GSTT1 positive

2

Random (P < 0.001)

0.79 (0.06– 10.87)

0.858

  GSTM1 positive + GSTT1 null

2

Fixed (P = 0.767)

0.62 (0.27– 1.43)

0.264

  GSTM1 null + GSTT1 null

2

Random (P = 0.074)

0.91 (0.15– 5.57)

0.919

Cataract type

    

Cortical

    

  GSTM1 null + GSTT1 positive

3

Fixed (P = 0.745)

0.82 (0.62– 1.10)

0.181

  GSTM1 positive + GSTT1 null

3

Fixed (P = 0.131)

1.39 (0.99– 1.96)

0.061

  GSTM1 null + GSTT1 null

3

Fixed (P = 0.171)

1.03 (0.72– 1.48)

0.855

Nuclear

    

  GSTM1 null + GSTT1 positive

2

Random (P = 0.030)

1.00 (0.39– 2.56)

0.994

  GSTM1 positive + GSTT1 null

2

Random (P = 0.081)

0.67 (0.11– 4.24)

0.668

  GSTM1 null + GSTT1 null

2

Fixed (P = 0.868)

1.16 (0.56– 2.38)

0.694

Posterior subcapsular

    

  GSTM1 null + GSTT1 positive

2

Random (P = 0.038)

1.20 (0.42– 3.39)

0.734

  GSTM1 positive + GSTT1 null

2

Fixed (P = 0.157)

1.15 (0.59– 2.26)

0.682

  GSTM1 null + GSTT1 null

2

Fixed (P = 0.399)

1.97 (0.98– 3.97)

0.059

Mixed

    

  GSTM1 null + GSTT1 positive

2

Random (P = 0.019)

0.81 (0.25– 2.61)

0.724

  GSTM1 positive + GSTT1 null

2

Fixed (P = 0.130)

1.22 (0.68– 2.21)

0.505

  GSTM1 null + GSTT1 null

2

Fixed (P = 0.523)

1.44 (0.74– 2.79)

0.279

aN: The number of included studies

bA random-effects or fixed-effects model was used in presence (P ≤ 0.10) or absence (P > 0.10) of heterogeneity of included studies and the P value was presented in parenthesis

Potential publication bias and sensitivity analysis

We firstly detected the publication bias by the Begg’s test for the overall pooled analyses of GSTM1 and GSTT1 null genotype, and found symmetric distribution of corresponding funnel plots for GSTM1 genotype with a P value of 0.138, and GSTT1 genotype with a P value of 0.754 (Fig. 3). However, the Egger’s test showed that the P values for GSTM1 and GSTT1 null genotype were 0.037 and 0.908 respectively, suggesting a publication bias for studies on GSTM1 but not GSTT1 genotype.
Fig. 3
Fig. 3

Funnel plots showed symmetric distribution. Log OR is plotted against the standard error of log OR for studies on GSTM1 (a) or GSTT1 null (b) polymorphism. The dots represent specific studies for the indicated association

Sensitivity analysis showed that exclusion of each study did not influence the result in specific genotype comparison for GSTM1 and GSTT1 polymorphism (Fig. 4), suggesting that the results of synthetic analysis were robust.
Fig. 4
Fig. 4

Sensitivity analyses for GSTM1 or GSTT1 null polymorphism. Sensitivity analysis was performed for GSTM1 (a) or GSTT1 null (b) polymorphism. Each study was deleted at a time in synthetic analysis to detect the influence of the omitted study. The hollow circles represent OR of pooled results with the deletion of each study. The ranges of horizontal dotted-lines represent the 95 % confidence intervals of the corresponding OR

Discussion

Before inclusion of studies, we briefly searched PubMed, Embase, Web of Science and China National Knowledge Infrastructure, and found that most of studies examined association of GSTM1 or GSTT1 polymorphisms with cataract risk while very limited studies were related to other GST polymorphisms, e.g., GSTM3, GSTO or GSTP polymorphisms. Thus, this meta-analysis only evaluated the effects of GSTM1 and GSTT1 ploymorphisms on cataract risk. Our data showed that GSTT1 but not GSTM1 null polymorphism was associated with cataract risk in Asians. Although different subtypes of cataract have their own pathogenesis and clinical characteristics, our meta-analysis data indicate that GSTT1 null polymorphism may contribute to increased risk of posterior subcapsular cataract.

In 1995, Sekine and colleagues for the first time reported possible correlation of GSTM1 null genotype frequency with cataract risk [36]. However, the following studies showed inconsistent results [18, 21–25, 32–35]. By pooling these early studies, previous meta-analysis by Sun et al., did not find an association of GSTM1 null genotype with cataract risk [6]. Even including three more studies, we did not find positive relationship between GSTM1 null genotype and cataract risk. To be noted, although previous meta-analysis indicated an association of GSTM1 null genotype and increased risk of cataract in Asians [6], our data did not confirm this association when including one more study on Asians.

For GSTT1 polymorphism, pooled four early studies on Caucasian showed no association [18, 22, 24, 25] while one study on Asians [21] showed positive association between GSTT1 null genotype and cataract risk; however, by pooling these five studies, no association was found [6]. By including four recent studies, our meta-analysis showed positive association of GSTT1 polymorphism with increased risk of cataract in all populations, and this association remained in Asians when two studies were pooling [15, 21]. Previous studies reported gender-dependent effects of GSTT1 null polymorphism on cataract risk [18, 22, 24]; however, recent two studies showed negative results [15, 16]. We performed a subgroup analysis stratified by gender with all five studies, and results showed no significant association, which was consistent with previous meta-analysis data based on three studies [6]. In addition, our data showed positive association of GSTT1 null polymorphism with increased risk of posterior subcapsular cataract although previous pooled study indicated that this association did not reach significant (OR, 1.21; 95 % CI, 0.96–1.53) [6]. Since the studies included for subgroup analyses were still limited, future studies are required to validate the association between GSTT1 null polymorphism and cataract risk.

To the best of our knowledge, the association between combination of GST polymorphisms and susceptibility to cataract has been assessed for the first time by our meta-analysis. The study by Juronen et al., firstly reported that the GSTM1 positive phenotype frequency was significantly higher in the cataract group than in the controls, and the cataract risk associated with the GSTM1 positive phenotype was increased in carriers of the combined GSTM1 positive and GSTT1 positive phenotypes [25]. However, a later study by Saadat et al., showed that individuals with the null genotypes for GSTM1 and GSTT1, or combination of GSTT1 positive and GSTM1 null genotypes were at a significantly higher risk for developing cataract than individuals with both the genes positive genotypes [24]. The following studies consecutively presented inconsistent results [15, 16, 18, 22]. By pooling seven studies, our meta-analysis results did not show a significant association between each combination of GSTM1 and GSTT1 genotypes and cataract risk. Two pooled studies with population-based controls showed that combination of GSTM1 null and GSTT1 positive genotypes played a protective role in cataract risk [16, 25]; however, this positive association was not found in other stratified analyses. Thus, the result should be interpreted with caution.

When compared to individual studies, the meta-analysis has a vital advantages. However, some potential limitations in our study should be considered. First, the inclusion of studies might not be sufficient since we only included published papers with language in English, or Chinese. It is possible that some papers published in other languages may not indexed by the database (e.g. PubMed, Embase, Web of Science). Thus, the publication bias for GSTM1 polymorphism detected in our study might be due to insufficient inclusion of published studies. Second, this meta-analysis was limited by the small sample size, especially in subgroup analyses aforementioned (e.g., studies on GSTT1 polymorphism in Asians), and this need further investigation. Third, basic methodological differences among the studies, e.g., ELISA vs. PCR assay for genotyping, might have affected the results. Fourth, most of the studies included did not categorize the cataract patients as cortical, nuclear, posterior subcapsular and mixed cataract. Although we found positive association between GSTT1 null polymorphism and increased risk of posterior subcapsular cataract, however, only four studies with available data were pooled [16, 18, 21, 25], and thus this association awaits further confirmation. Fifth, the primary outcome measure was calculated based on individual unadjusted ORs, which might affect the evaluation precision of the study. The lack of detailed data in each study prevented multiple testing for combined effects of gene-environment factors on cataract risk, and thus future studies should address this point. Last, the Caucasian and Asian subjects from different countries might have been genetically heterogeneous, e.g., different lifestyle and environment (e.g., European vs. Arabian). These factors may explain the heterogeneity in this meta-analysis for Caucasian subjects.

Conclusion

In summary, the present meta-analysis showed that the association between GSTM1 null polymorphism and cataract risk was either negative or evidence limited. The GSTT1 null polymorphism was significantly associated with increased risk of posterior subcapsular cataract. Given the limited study populations, more studies with large study population are suggested to further validate the relationship between GST polymorphisms and genetic predisposition to cataract, e.g., association of GSTT1 null polymorphism with cataract risk in Asian.

Notes

Declarations

Acknowledgement

This work was supported by the National Natural Science Foundation of China (81200717), the Zhejiang Provincial Educational Bureau Foundation, China (Y201223905), and the Qianjiang Talents Program of Zhejiang Province, China (2013R10041). The study sponsors had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.

Financial disclosure

This work was supported by the National Natural Science Foundation ofChina (81200717), the Zhejiang Provincial Educational Bureau Foundation, China (Y201223905), and the Qianjiang Talents Program of Zhejiang Province, China (2013R10041). The funders have no role in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.

Authors’ Affiliations

(1)
Department of Ophthalmology, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Road, Hangzhou, 310003, China
(2)
Department of Public Health, Zhejiang University School of Medicine, 866 Yuhangtang Road, 310058 Hangzhou, China

References

  1. Asbell PA, Dualan I, Mindel J, Brocks D, Ahmad M, Epstein S. Age-related cataract. Lancet. 2005;365:599–609.View ArticlePubMedGoogle Scholar
  2. West S. Epidemiology of cataract: accomplishments over 25 years and future directions. Ophthalmic Epidemiol. 2007;14:173–8.View ArticlePubMedGoogle Scholar
  3. Robman L, Taylor H. External factors in the development of cataract. Eye (Lond). 2005;19:1074–82.View ArticleGoogle Scholar
  4. Shiels A, Hejtmancik JF. Genetic origins of cataract. Arch Ophthalmol. 2007;125:165–73.View ArticlePubMedGoogle Scholar
  5. Yang J, Luo J, Zhou P, Fan Q, Luo Y, Lu Y. Association of the ephreceptor tyrosinekinase-type A2 (EPHA2) gene polymorphism rs3754334 with age-related cataract risk: a meta-analysis. PLoS One. 2013;8:e71003.View ArticlePubMedPubMed CentralGoogle Scholar
  6. Sun L, Xi B, Yu L, Gao XC, Shi DJ, Yan YK, et al. Association of glutathione S-transferases polymorphisms (GSTM1 and GSTT1) with senile cataract: a meta-analysis. Invest Ophthalmol Vis Sci. 2010;51:6381–6.View ArticlePubMedGoogle Scholar
  7. Fletcher AE. Free radicals, antioxidants and eye diseases: evidence from epidemiological studies on cataract and age-related macular degeneration. Ophthalmic Res. 2010;44:191–8.View ArticlePubMedGoogle Scholar
  8. Berthoud VM, Beyer EC. Oxidative stress, lens gap junctions, and cataracts. Antioxid Redox Signal. 2009;11:339–53.View ArticlePubMedPubMed CentralGoogle Scholar
  9. Vinson JA. Oxidative stress in cataracts. Pathophysiology. 2006;13:151–62.View ArticlePubMedGoogle Scholar
  10. Strange RC, Jones PW, Fryer AA. Glutathione S-transferase: genetics and role in toxicology. Toxicol Lett. 2000;112–113:357–63.View ArticlePubMedGoogle Scholar
  11. Polimanti R, Carboni C, Baesso I, Piacentini S, Iorio A, De Stefano GF, et al. Genetic variability of glutathione S-transferase enzymes in human populations: functional inter-ethnic differences in detoxification systems. Gene. 2013;512:102–7.View ArticlePubMedGoogle Scholar
  12. Josephy PD. Genetic variations in human glutathione transferase enzymes: significance for pharmacology and toxicology. Hum Genomics Proteomics. 2010;2010:876940.View ArticlePubMedPubMed CentralGoogle Scholar
  13. Di Pietro G, Magno LA, Rios-Santos F. Glutathione S-transferases: an overview in cancer research. Expert Opin Drug Metab Toxicol. 2010;6:153–70.View ArticlePubMedGoogle Scholar
  14. Yu Y, Weng Y, Guo J, Chen G, Yao K. Association of glutathione S transferases polymorphisms with glaucoma: a meta-analysis. PLoS One. 2013;8:e54037.View ArticlePubMedPubMed CentralGoogle Scholar
  15. Jiang Z, Liang K, Zhang Q, Tao L. Glutathione S-transferases polymorphisms confer susceptibility to senile cortical cataract in the Han Chinese population. Mol Vis. 2012;18:1247–52.PubMedPubMed CentralGoogle Scholar
  16. Sireesha R, Laxmi SG, Mamata M, Reddy PY, Goud PU, Rao PV, et al. Total activity of glutathione-S-transferase (GST) and polymorphisms of GSTM1 and GSTT1 genes conferring risk for the development of age related cataracts. Exp Eye Res. 2012;98:67–74.View ArticlePubMedGoogle Scholar
  17. Saadat I, Ahmadi Z, Farvardin-Jahromi M, Saadat M. Association between cataract and genetic polymorphisms of GSTM1, GSTT1, and GSTO2 with respect of work place. Mol Vis. 2012;18:1996–2000.PubMedPubMed CentralGoogle Scholar
  18. Guven M, Unal M, Sarici A, Ozaydin A, Batar B, Devranoglu K. Glutathione-S-transferase M1 and T1 genetic polymorphisms and the risk of cataract development: a study in the Turkish population. Curr Eye Res. 2007;32:447–54.View ArticlePubMedGoogle Scholar
  19. Hayashino Y, Noguchi Y, Fukui T. Systematic evaluation and comparison of statistical tests for publication bias. J Epidemiol. 2005;15:235–43.View ArticlePubMedGoogle Scholar
  20. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088–101.View ArticlePubMedGoogle Scholar
  21. Zhou J, Hu J, Guan H. The association between copy number variations in glutathione S-transferase M1 and T1 and age-related cataract in a Han Chinese population. Invest Ophthalmol Vis Sci. 2010;51:3924–8.View ArticlePubMedGoogle Scholar
  22. Abdel Azeem AA, Mahmoud AA, Salaheldine MM, Amr K. Implication of glutathione S-transferase M1 and T1 polymorphisms in the development of senile cataract among Egyptians. Bratisl Lek Listy. 2009;110:678–83.PubMedGoogle Scholar
  23. Saadat M, Farvardin-Jahromi M. Occupational sunlight exposure, polymorphism of glutathione S-transferase M1, and senile cataract risk. Occup Environ Med. 2006;63:503–4.View ArticlePubMedPubMed CentralGoogle Scholar
  24. Saadat M, Farvardin-Jahromi M, Saadat H. Null genotype of glutathione S-transferase M1 is associated with senile cataract susceptibility in non-smoker females. Biochem Biophys Res Commun. 2004;319:1287–91.View ArticlePubMedGoogle Scholar
  25. Juronen E, Tasa G, Veromann S, Parts L, Tiidla A, Pulges R, et al. Polymorphic glutathione S-transferases as genetic risk factors for senile cortical cataract in Estonians. Invest Ophthalmol Vis Sci. 2000;41:2262–7.PubMedGoogle Scholar
  26. Bu L, Yan S, Jin M, Jin Y, Yu C, Xiao S, et al. The gamma S-crystallin gene is mutated in autosomal recessive cataract in mouse. Genomics. 2002;80:38–44.View ArticlePubMedGoogle Scholar
  27. Prchal JT, Conrad ME, Skalka HW. Association of presenile cataracts with heterozygosity for galactosaemic states and with riboflavin deficiency. Lancet. 1978;1:12–3.View ArticlePubMedGoogle Scholar
  28. Othman H, Gholampour AR, Saadat I, Farvardin-Jahromoi M, Saadat M. Age-related macular degeneration and genetic polymorphisms of glutathione S-transferases M1 (GSTM1) and T1 (GSTT1). Mol Biol Rep. 2012;39:3299–303.View ArticlePubMedGoogle Scholar
  29. Juronen E, Tasa G, Veromann S, Parts L, Tiidla A, Pulges R, et al. Polymorphic glutathione S-transferase M1 is a risk factor of primary open-angle glaucoma among Estonians. Exp Eye Res. 2000;71:447–52.View ArticlePubMedGoogle Scholar
  30. Stamenkovic M, Radic T, Stefanovic I, Coric V, Sencanic I, Pljesa-Ercegovac M, et al. Glutathione S-transferase omega-2 polymorphism Asn142Asp modifies the risk of age-related cataract in smokers and subjects exposed to ultraviolet irradiation. Clin Experiment Ophthalmol. 2013;42:277–83.Google Scholar
  31. Chandra A, Raza ST, Abbas S, Singh L, Rizvi S, Ahmed F et al. Polymorphism of GST and FTO Genes in Risk Prediction of Cataract among a North Indian Population. Ophthalmic Genet. In press.Google Scholar
  32. Xu M, Fu S, L Z. Relationship between GSTM1 gene deletion and susceptibility to senile cataract. Acta Acad Med Jiangxi. 2007;47:33–8.Google Scholar
  33. Hao Y, He S, Gu Z, Zhao Y, Li X, Wang C, et al. Relationship between GSTM1 genotype and susceptibility to senile cataract. Zhonghua Yan Ke Za Zhi. 1999;35:104–6.PubMedGoogle Scholar
  34. Pi J, Bai Y, Zheng Q. A study on relationship between glutathione S-transferase mu gene deletion and senile cataract susceptibility. Zhonghua Yan Ke Za Zhi. 1996;32:224–6.PubMedGoogle Scholar
  35. Alberti G, Oguni M, Podgor M, Sperduto RD, Tomarev S, Grassi C, et al. Glutathione S-transferase M1 genotype and age-related cataracts. Lack of association in an Italian population. Invest Ophthalmol Vis Sci. 1996;37:1167–73.PubMedGoogle Scholar
  36. Sekine Y, Hommura S, Harada S. Frequency of glutathione-S-transferase 1 gene deletion and its possible correlation with cataract formation. Exp Eye Res. 1995;60:159–63.View ArticlePubMedGoogle Scholar

Copyright

© Sun et al. 2015

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement

BMC Ophthalmology

ISSN: 1471-2415

Contact us